Antisense Therapeutics (ASX:ANP) has received positive feedback from the US FDA on plans to conduct an IND-enabling phase IIb trial of MS drug candidate ATL1102.

Law firm Morrison & Foerster (MoFo) has released its Q3 edition of BioMeter. The quarterly report measures the health of the biotech industry. [ + ]

The US-based Seahorse Bioscience and Moffitt Cancer Center have received an SBIR contract, through the National Cancer Institute, to develop a reproducible method that will enable the measurement of metabolism of 3D microtissue. [ + ]

The AusBiotech national conference will this week bring together the entire biotechnology 'ecosystem' to share ideas and progress their biotechnology development work.

Researchers from the Cornell University Food and Brand Lab have found that graphs or formulas accompanying medical information can lead consumers to believe products are more effective, despite not actually providing additional evidence. [ + ]

Researchers have disputed the claim that ancient Egyptian royal families suffered from the systemic disease ankylosing spondylitis, which causes inflammation of the spinal joints. [ + ]

ResMed (ASX:RMD) has reported its results for its fiscal first quarter and has unveiled new and improved patient management platforms for its sleep-disordered breathing treatment devices.

Alchemia (ASX:ACL) Chief Scientific Officer Dr Tracey Brown has won the Telstra Victorian Business Woman of the Year award and is now eligible to win the national award as well.

The annual Women in Nuclear (WiN) Global Award has been won by Dr Margaret Elcombe of the Australian Nuclear Science and Technology Organisation (ANSTO) - the first Australian ever to receive the award. [ + ]

The Medical Research Commercialisation Fund has granted $1m in financing to early-stage anti-infectives company Auspherix.

In a world first, the Australian Government has announced it will make 100 years of intellectual property (IP) rights data available online in order to make finding collaboration partners easier and allow the mapping of innovation.

The Australian Government has allocated $580.2 million to help Australian health and medical researchers find the cures, treatments and medical devices of the future. [ + ]

Clinical Genomics and the CSIRO have signed an international licensing agreement covering their jointly developed blood test for bowel cancer.

The Australian Government has allocated $580.2 million to fund 848 National Health and Medical Research Council (NHMRC) grants.

AusBiotech said in its submission to the Inquiry into the 'Tax and Superannuation Laws Amendment (2014 Measures No 5) Bill 2014' that the seemingly small but not benign change, announced in the May 2014 Federal Budget, will permanently impact companies in tax loss.